![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, March 28, 2017 1:32:40 PM
VDRM's CEO Dr. Otiko and/or whoever mans the investor relations email address/phones hasn't gotten back to me and many other investors about dilution/patents clarification, just the select two or three who also happen to be the stock's biggest proponents. Additionally, there is talk that VDRM's new Canadian investors (who haven't been named ANYWHERE, IN ANY MEDIA) also happen to be big movers and shakers in the medical marijuana industry. Now, I'm not calling this a scam, just saying that it's very interesting how this comes out right when the stock is at a new low and no PR or media has been released to substantiate it. Hmmm...
So... after speaking with two of VDRM's CEO Dr. Otiko's former business partners, I have his direct contact information: 2 email addresses and a cell phone number. DM me your email address and I'll shoot them over to you so you can try to get info on the record. Or if it's not against the rules of the room, I'll post here. Let me know. Don't want to violate the rules of the board.
FEATURED Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM